Engineered Tissue Solutions (ETS) Revenue and Competitors
Estimated Revenue & Valuation
- Engineered Tissue Solutions (ETS)'s estimated annual revenue is currently $11.5M per year.
- Engineered Tissue Solutions (ETS)'s estimated revenue per employee is $303,158
Employee Data
- Engineered Tissue Solutions (ETS) has 38 Employees.
- Engineered Tissue Solutions (ETS) grew their employee count by 31% last year.
Engineered Tissue Solutions (ETS)'s People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Operating Officer | Reveal Email/Phone |
2 | Customer Operations Specialist | Reveal Email/Phone |
Engineered Tissue Solutions (ETS) Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 88 | 24% | N/A | N/A |
#2 | $3.5M | 36 | 44% | N/A | N/A |
#3 | $55.6M | 133 | 12% | N/A | N/A |
#4 | $8.2M | 27 | 17% | N/A | N/A |
#5 | $0.3M | 2 | N/A | N/A | N/A |
#6 | $35M | 138 | 22% | N/A | N/A |
#7 | $7.5M | 89 | 6% | N/A | N/A |
#8 | $5.6M | 21 | 24% | N/A | N/A |
#9 | $3.5M | 3 | 0% | N/A | N/A |
#10 | $12.3M | 40 | 43% | N/A | N/A |
What Is Engineered Tissue Solutions (ETS)?
Engineered Tissue Solutions (ETS) is an emerging wound care company, re-defining wound care with cutting-edge bioactive glass technology that reduces healing time, minimizes treatment costs and improves patient outcomes.\n\nOur flagship product, MIRRAGEN® Advanced Wound Matrix, is a next-generation intervention for wound healing. Using synthetic, absorbable bioactive glass fiber technology, MIRRAGEN accelerates healing, decreases wound area, reduces costs, and is safe and easy to use.
keywords:N/AN/A
Total Funding
38
Number of Employees
$11.5M
Revenue (est)
31%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.4M | 48 | 17% | N/A |
#2 | $11.3M | 51 | 2% | N/A |
#3 | $12.6M | 52 | -2% | N/A |
#4 | $10.3M | 52 | 4% | N/A |
#5 | $18.1M | 53 | 26% | N/A |